Pharmafile Logo
Pharmafocus logo
Advanced Search
astrazeneca_plaque

AstraZeneca CEO suggests he’s the ‘lowest paid CEO in the whole industry’ as he raises concerns surrounding Brexit

September 25, 2018
Business Services, Research and Development

Pascal Soriot, the Chief Executive Officer of the Anglo-Swedish multinational AstraZeneca, has raised concerns that he is being underpaid, despite …

News
white-blood-cell-543471_1920

NICE decision could limit future development of CAR T therapies; Evelyn Warner comments on NICE’s decision making process

September 25, 2018
Research and Development CAR T, CAR-T, Cancer, Duff and Phelps, Kymriah, access, oncology, pricing

Lack of access to CAR T therapies in the United Kingdom could hinder the development of effective personalised cancer treatments, …

News
29496564944_a9faceb1c2_z

President Trump pledges to fight drug addiction at UN meeting

September 25, 2018
Manufacturing and Production Trump, UN, drugs, illicit drugs, trafficking

President Donald Trump has pledged to fight “the scourge of drug addiction,” as he outlined his commitment to the fight …

News

Roche’s entrectinib shrinks lung tumours with two-year response duration

September 25, 2018
Manufacturing and Production, Research and Development, Sales and Marketing Cancer, NSCLC, NSCLC< lung cancer, Roche, entrectinib

Roche was unveiled new Phase 1 and 2 data for entrectinib in the treatment of locally advanced or metastatic ROS1-positive …

News
jj_sign_on_wall

J&J pledges to end global TB pandemic

September 25, 2018
Manufacturing and Production J&J, JJ, Johnson and Johnson, TB, access, tuberculosis

Johnson and Johnson have announced that they are launching a 10-year initiative aimed at helping to end tuberculosis, the world’s …

News
novartis_outside_1

Novartis cuts more than 2500 jobs in Switzerland and the UK

September 25, 2018
Manufacturing and Production Basel, Jobs, Novartis, Switzerland, grimsby, manufacturing

Swiss multinational Novartis are set to cut thousands of jobs across Europe in an effort to boost profitability. The move …

News
astrazeneca_building_white

AstraZeneca chalks up European approval for Imfinzi in locally advanced, unresectable lung cancer

September 25, 2018
Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, MedImmune, NSCLC, lung cancer, pharma

AstraZeneca and its global biologics R&D arm MedImmune have announced the approval by the European Commission of Imfinzi (durvalumab) as …

News

Working Life: Jean-Christophe Tellier, CEO of UCB Pharma

September 24, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UCB, Working Life, feature

Just as his company announced robust H1 2018 financials, UCB’s Jean-Christophe Tellier spoke to Pharmafocus to share his experiences of …

Feature
6813384933_1fb31d73fb_z

HIV on the rise among straight men in Australia

September 24, 2018
Medical Communications, Sales and Marketing AIDS, Aboriginal, Australia, HIV, Kirby Institute

The number of new HIV diagnoses is on the rise among heterosexual men in Australia, according to a new report …

News
7359dba7-e1da-4eb4-8765-58da6178899b

Sarepta’s Exondys 51 hit with negative CHMP opinion in Duchenne muscular dystrophy

September 24, 2018
Research and Development, Sales and Marketing CHMP, Duchenne Muscular Dystophy, EMA, Europe, Exondys 51, pharma, sarepta

Sarepta Therapeutics has been rocked by a hurdle in its pursuit of regulatory approval in Europe, as the company revealed …

News

Courts back NHS in fight against Novartis and Bayer

September 24, 2018
Sales and Marketing Bayer, Eylea, NHS, Novartis, avastin, ludentis

The NHS has won a court case against multinational pharmaceutical firms Novartis and Bayer, after the companies sought to block …

News
calvarycemeteryqueens_edit

Life expectancy falls in America; drugs, alcohol and suicide to blame

September 24, 2018
Sales and Marketing USA, alcohol, drugs, health, opiod crisis, suicide

Life expectancy has fallen for the second year in a row for people in the United States, according to new …

News
astrazeneca-sign

AstraZeneca’s Farxiga cuts heart risk in type 2 diabetes patients

September 24, 2018
Research and Development, Sales and Marketing AstraZeneca, diabetes, farxiga, pharma

AstraZeneca has unveiled new Phase 3 data for its SGLT2 inhibitor Farxiga (dapagliflozin), showing with the drug demonstrating positive findings …

News
humira_abbott__4

EU approval for Mylan and Fujifilm’s Humira biosimilar

September 21, 2018
Medical Communications, Sales and Marketing EU, Europe, Humira, Mylan, biosimilar, pharma

The European Commission has approved its fifth biosimilar of the world’s best-selling drug, Abbvie’s Humira (adalimumab), granting marketing authorisation to …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

September 21, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jobs, Novartis, Novo Nordisk, Senate, UCB, manufacturing, opioid crisis, top 10

Manufacturing took a hit this week as Novo Nordisk announced the loss of 400 jobs while Novartis made the move …

News

ABPI forges five year partnership with AHSN focused on increased uptake of transformative biomedical innovations into the NHS

September 21, 2018
Medical Communications ABPI, NHS, UK, ahsn, collaboration

The Association of the British Pharmaceutical Industry (ABPI) has announced that it is forging a five year partnership with the …

News
1920px-hiv-budding-color

British MPs call for HIV prevention PrEP drugs to be made available on NHS in England

September 21, 2018
Medical Communications

PrEP drugs – pre-sex drugs that are able to dramatically reduce the chances a person has of contracting HIV – …

News
opioid_pills

Surgeon General calls for cultural shift in approach to opioid crisis

September 21, 2018
Medical Communications Trump, US, opioid crisis, opioid epidemic, surgeon general

The Surgeon General of the United States has called for a cultural shift in the way in which Americans talk …

News

Shares in Molecular Templates surge after the announcement of Takeda collaboration

September 20, 2018
Business Services, Research and Development Molecular Templates, Shares, Takeda, markets, stocks

Shares in the Texas based biotech Molecular Templates have soared after the company announced that they would be collaborating with …

News
alzheimers_pharmafocus_accompanying_image

A goal in mind: Transforming the way Alzheimer’s disease is diagnosed and treated

September 20, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Roche, pharma

Dr Rachelle Doody, Global Head of Neurodegeneration at Roche/Genentech, discusses key learnings from clinical trials in Alzheimer’s disease, and how …

Feature
The Gateway to Local Adoption Series

Latest content

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026